Zetzmann-Krien, Diane (Bremen (govt) 201110 Managing Director of Bremer Aubau-Bank GmbH) |
Managing Director |
Bremen (govt region) |
Germany |
Zettlmeissl, Gerd (Intercell 2005–201105 CEO before COO since 2001 before Chiron Behring before Behringwerke) |
Chief Executive Officer (CEO) |
Valneva (Group) |
Austria |
Zettl, Sophie (CEBINA 202003 before Arsanis + MedImmune/AZ) |
Business Development Manager / Strategy Manager |
CEBINA GmbH (Central European Biotech Incubator and Accelerator) |
Austria |
Zettl, Rolf (Helmholtz 201502 Managing Director) |
Managing Director |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
Zettl, Rolf (Combinature co-founder + CEO 200011–200504 afterwards CBO) |
Chief Business Officer (CBO) |
MerLion (Group) |
Germany |
Zerrer, Ralf (Clariant 201801 Head Strategic Marketing + Innovation at Business Unit Industrial + Consumer Specialties) |
Sales Manager / Marketing Manager |
Clariant (Group) |
Switzerland |
Zerhouni, Elias A. (Sanofi-Aventis 201101– President Global RnD before NIH Director 2002–2008) |
Research & Development Manager |
Sanofi (Group) [since May 2011] |
France |
Zepp, Tobias (CRS Clinical Research Services 201706 Corporate Communications Manager) |
Public Relations Manager / Investor Relations Manager |
CRS Clinical Research Services (Group) |
Germany |
Zentgraf, Martin (Desitin 201202 General Manager of Desitin Arzneimittel GmbH) |
General Manager (management) |
Desitin Arzneimittel GmbH |
Germany |
Zenobi, Renato (ETH Zürich 201006 Professor Dept of Chemistry) |
Professor |
ETH Zürich (ETHZ) |
Switzerland |
Zenker, Othmar (InflaRx 201706– CMO before Head Clinical Research + Development since 2013 before CSL Behring) |
Research & Development Manager |
InflaRx (Group) |
Germany |
Zenker, Matthias (GAIA 201702 Business Development) |
Business Development Manager / Strategy Manager |
GAIA AG |
Germany |
Zencke, Peter (MeVis Medical Solutions 200708–201106 Supervisory Board Member) |
Supervisory Board Member |
Varian Medical Systems (Group) |
Germany |
Zeltz, Patric (BadenBioTec 201104 Managing Director before BF-Biolabs 200312– founder) |
Managing Director |
BadenBioTec GmbH |
Germany |
Zeltner, Jürg (UBS 201604 President of UBS Wealth Management) |
President/Director/Head Business Group/Unit/Division |
UBS (Group) |
Switzerland |
Zeller, Marco (VC Fonds Berlin 200508 Managing Director) |
Managing Director |
Berlin (govt region) |
Germany |
Zell, Andreas |
n. a. |
University of Tübingen (Eberhard-Karls-Universität) |
Germany |
Zeise, Antje (Epigenomics 201112 Manager IR | PR) |
Public Relations Manager / Investor Relations Manager |
Epigenomics (Group) |
Germany |
Zeinali, Sirous (Genetek Biopharma 201805 Managing Director + Co-Founder) |
Managing Director |
Genetek Biopharma GmbH |
Germany |
Zeidler, Reinhard (Helmholtz 201801 Prof Gene Vectors Research Unit at Helmholtz Zentrum München) |
Professor |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
Zehntner, Heiner (Endress+Hauser 201309 Member of Executive Board) |
Board member, executive |
Endress+Hauser (Group) |
Switzerland |
Zehnder, Alexander (CureVac 202304– CEO before Sanofi + Roche/Genetech) |
Chief Executive Officer (CEO) |
CureVac (Group) |
Germany |
Zehetmayer, Peter (Acquifer Imaging 202301 COO + Director for Sales + Marketing) |
Chief Operating Officer (COO) |
Bruker (Group) |
Germany |
Zehethofer, Karl |
n. a. |
Greiner (Group) |
Austria |
Zeh, Alexander (Tacalyx 202205 Head of Finance + Administration) |
Chief Financial Officer (CFO) |
Tacalyx GmbH |
Germany |
Zechner, Rudolf (Univ Graz 201308 Professor at Instittue for Molecular Biosciences) |
Professor |
University of Graz (Karl-Franzens-Universität) |
Austria |
Zech, Birgit (Anavo Therapeutics 202104 CEO before Gotham Therapeutics + X-Rx + MAB Discovery + Pieris + Axxima) |
Chief Executive Officer (CEO) |
Anavo Therapeutics (Group) |
Netherlands |
Zbinden, Laurent (MedXCell 202203 CEO) |
Chief Executive Officer (CEO) |
MedXCell (Group) |
Switzerland |
Zbar, Brett (General Atlantic 202009– Managing Director + Global Head Life Sciences before Foresite Capital + Aisling) |
Managing Director |
General Atlantic (Group) |
United States (USA) |
Zazulina, Victoria (Merck (DE) 202209 Head of Development Unit Oncology before Boehringer Ingelheim) |
President/Director/Head Business Group/Unit/Division |
Merck (DE) (Group) |
Germany |
Zauderer, Maurice (Vaccinex 200803 CEO) |
Chief Executive Officer (CEO) |
Vaccinex Inc. |
United States (USA) |
Zarrehparvar, Mazi (MicrobeDx 201701 CEO) |
Chief Executive Officer (CEO) |
MicrobeDx (Group) |
United States (USA) |
Zapico, David A. (AMETEK 201608 CEO) |
Chief Executive Officer (CEO) |
AMETEK (Group) |
United States (USA) |
Zanzinger, Johannnes (Boehringer 202001 at BIVF) |
Investment Manager |
Boehringer Ingelheim (Group) |
Germany |
Zang, Jingwu (I-Mab 201711 CEO + Founder of I-Mab Biopharma before GSK RnD China 200705 Head) |
Chief Executive Officer (CEO) |
GSK (Group) |
United Kingdom (GB) |
Zanchi, Marta-Gaia (Nina Capital 202011 Founder + Managing Partner) |
Partner (venture partner) |
Nina Capital SGEIC S.A. |
Spain (España) |
Zampieri, Gianni (Galenica Group 201702 CEO of Vifor Pharma) |
Chief Executive Officer (CEO) |
Vifor Pharma (Group) |
Switzerland |
Zamboni, Nicola (ETH Zurich 201007 Institute of Molecular Systems Biology) |
Researcher (university / research institute) |
ETH Zürich (ETHZ) |
Switzerland |
Zambon, Elena (Zambon 201907 President) |
Board member |
Zambon (Group) |
Italy |
Zaimenko, Inna (Versatile Biology Lab 202210 Founder) |
Company Founder |
Versatile Biology Lab (Inna Zaimenko) |
Germany |
Zahnd, Christian (Molecular Partners 200708 CEO RESIGNED 11/16) |
Chief Executive Officer (CEO) |
Molecular Partners AG (SIX: MOLN, Nasdaq: MOLN) |
Switzerland |
Zahn, Ralph (Priavoid 201709– Co-Founder formerly Biocrates 201306 CTO) |
Chief Technology/Technical Officer (CTO) |
Priavoid GmbH |
Germany |
Zahn, Grit (Eternygen GmbH 201309– Head of Research before ipal GmbH + Jerini) |
Research & Development Manager |
Eternygen (Group) |
Germany |
Zahn, Dorothea (BST Bio Sensor Technology GmbH 201110 Managing Director) |
Managing Director |
BST Bio Sensor Technologie GmbH |
Germany |
Zafirakos, Elias (BioPeople (DK) 201404 Science Liaison Officer) |
Cluster Manager |
Biopeople (Denmark’s Life Science Cluster) |
Denmark |
Zachmann, Julian (Strüngmann Group 202308 Investment Manager before HTGF) |
Investment Manager |
STRÜNGMANN Group (family Strüngmann) |
Germany |
Zachert, Matthias (Lanxess 201401– CEO before Merck (DE) CFO) |
Chief Executive Officer (CEO) |
Lanxess (Group) |
Germany |
Zacharias, Dietmar (Hochschule Bremen 201303 Professor for Applied + Ecological Botanics) |
Professor |
University of Applied Sciences Bremen (Hochschule Bremen) |
Germany |
Zaby, Andreas (Curacyte 200601) |
n. a. |
Curacyte (Group) |
Germany |
Zabrowski, Dan (Roche 201202– Head Roche Applied Science before Roche Global Head Pharma Partnering) |
President/Director/Head Business Group/Unit/Division |
Roche (Group) |
United States (USA) |
Zabel, Nina (BioRegio STERN 201802–) |
Cluster Manager |
BioRegio STERN Management GmbH |
Germany |
Yönel, Mutlu (Prosion 202308 Managing Director (CFO) + Co-Founder) |
Chief Financial Officer (CFO) |
Prosion GmbH (Prosion Therapeutics) |
Germany |
Yzer, Cornelia (Berlin (govt) 201305 Senator of Economy, Technology, and Research) |
Minister |
Berlin (govt region) |
Germany |
Yver, Antoine (AstraZeneca 201309 VP + Head of Oncology in Global Medicines Development Unit) |
President/Director/Head Business Group/Unit/Division |
AstraZeneca (Group) |
United Kingdom (GB) |
Yusibov, Vidadi (Fraunhofer USA 201009 Exec Director CMB + iBio 201009 CSO) |
Researcher (university / research institute) |
Fraunhofer (Group) |
United States (USA) |
Yule, Murray (iOmx Therapeutics 202202– CMO before MorphoSys) |
Chief Medical Officer (CMO) |
iOmx Therapeutics AG |
Germany |
Yu, Guo-Liang (Epitomics 201105 CEO) |
Chief Executive Officer (CEO) |
Abcam (Group) |
United States (USA) |
Yu, Frank (Ally Bridge Group 201702 CEO + CIO + Founder) |
Chief Executive Officer (CEO) |
Ally Bridge Group (ABG) |
China |
Yu, Chen (TCG Crossover 202107 Managing Partner + Founder before Vivo Capital 201504 Managing Partner) |
Managing Partner (investment firm) |
Column Group LLC, The (TCG) |
United States (USA) |
Yrjänheikki, Juha (Aurealis Pharma 201708 CEO) |
Chief Executive Officer (CEO) |
Aurealis Therapeutics AG |
Switzerland |
Yousaf, Shaf (Sigma-Aldrich 201412 VP Tech + BusDev before Life Technologies + Applied Biosystems + Sigma-Aldrich) |
President/Director/Head Business Group/Unit/Division |
Thermo Fisher (Group) |
United States (USA) |
Young, Joshua (Bruker 201301– VP Investor Relations before Merck KGA + Millipore LEFT BEFORE 7/16) |
Public Relations Manager / Investor Relations Manager |
Bruker (Group) |
United States (USA) |
Young, Jordan (Repare Therapeutics 202305 Director of SNIPRx platform) |
n. a. |
|
|
Young, Diane (Novartis Oncology 200601) |
n. a. |
Novartis (Group) |
Switzerland |
Yoshitaka, Shinsuke (Denka 201508 President + CEO) |
Chief Executive Officer (CEO) |
Denka (Group) |
Japan |
York, Gwill (Lighthouse Capital Partners 202110 Founding Managing Director) |
Managing Director |
Lighthouse Capital Partners (US) |
United States (USA) |
Yoo, Stephen (Anjarium Biosciences 202206– CEO before Third Harmonic Bio + Regenxbio + MedImmune + Abbott Labs) |
Chief Executive Officer (CEO) |
Anjarium Biosciences AG |
Switzerland |
Yoder, Stephen S. (Steve) (Pieris 201001– CEO before MorphoSys Head Licensing + IP) |
Chief Executive Officer (CEO) |
Pieris (Group) |
Germany |
Ylisaukko-oja, Tero (MedEngine Oy 201901 CEO) |
Chief Executive Officer (CEO) |
|
|
Yildiz, Marius (Murat) (Avergen Pharmaceuticals GmbH 201510– Managing Director) |
Managing Director |
Avergen Pharmaceuticals GmbH (APG) |
Germany |
Yianni, John (CryoTherapeutics GmbH 201305 Managing Director) |
Managing Director |
CryoTherapeutics GmbH |
Germany |
Yerganian, Syrane (Strammer 201704 CFO) |
Chief Executive Officer (CEO) |
Strammer (Group) |
France |
Yemm, Stephen (Steve) (Optibrium 202301– Chief Commercial Officer before Paradigm4 + Aigenpulse + BioData + Vialis) |
Chief Commercial Officer (CCO) |
Optibrium (Group) |
United Kingdom (GB) |
Yee, Sidney (Singapore (govt) 201510 CEO of DxD Hub of A*STAR) |
Chief Executive Officer (CEO) |
Singapore (govt) |
Singapore |
Yeager, Frank (Eckert & Ziegler 202305– promoted to Management Board Director for Isotope Products) |
Board member, executive |
Eckert & Ziegler (Group) |
Germany |
Yates, Robert (Merck (DE) 201109–201493 President of Merck Millipore before Roche Diagnostics LEFT 3/14) |
President/Director/Head Business Group/Unit/Division |
Merck (DE) (Group) |
United States (USA) |
Yaspo, Marie-Laure |
n. a. |
Source BioScience (Group) |
Germany |
Yap, Richard (Numares 201612– Managing Director of Numares Singapore before Avdisor + OrbusNeich) |
Managing Director |
Numares (Group) |
Singapore |
Yap, Greg (Menlo Ventures 202101 Partner formerly Desy + GE + Ventana + Cellective Dx + Affymetrix) |
Partner (venture partner) |
Menlo Ventures |
United States (USA) |
Yang, Zhi (BVCF Management 202105 Chairman + Managing Partner + Founder) |
Managing Partner |
BVCF Management Ltd. (CN) (BioVeda China Fund) |
China |
Yang, Xiaoming (Sinopharm 201704 Chairman of China National Biotech Group) |
President/Director/Head Business Group/Unit/Division |
Sinopharm (China National Pharmaceutical) (Group) |
China |
Yang, Steve (WuXi PharmaTech 201604 EVP + COO of WuXi AppTec) |
Chief Operating Officer (COO) |
WuXi PharmaTech (Group) |
China |
Yang, Patrick (National Resilience 202106 Exec Vice Chairman + Board Member at Antheia formerly Roche/Genentech) |
Board member, executive |
National Resilience (Group) |
United States (USA) |
Yang, Jerry (HCVC 202211 General Partner) |
General Partner (venture partner) |
HCVC (Hardware Club VC) |
France |
Yanchik, Joseph A., III (Aileron Therapeutics 201008 CEO) |
Chief Executive Officer (CEO) |
Aileron Therapeutics Inc. |
United States (USA) |
Yan, Zhiyu (Alan) (Sperogenix Therapeutics 202201 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
|
|
Yamane, Kenji (KKR 201506 President of Panasonic Healthcare + Panasonic Healthcare Holdings) |
President/Director/Head Business Group/Unit/Division |
PHC (Group) |
Japan |
Yamanaka, Shinya (Univ Kyoto 201004– Director of CiRA + Nobel Laureate 2012) |
Professor |
University of Kyoto (Kyoto University) |
Japan |
Yamamoto, Kazuhiko (Synplogen 202212 CEO) |
Chief Executive Officer (CEO) |
Synplogen Co., Ltd. |
Japan |
Yakneen, Sergei (Alphabet 202205– CTO at Isomorphic Labs before Sophia Genetics + Amazon + BPS) |
Chief Technology/Technical Officer (CTO) |
Alphabet (formerly Google) (Group) |
United Kingdom (GB) |
Yadegardjam, Farsin (EVP Capital 201106 Executive Board Director) |
Board member, executive |
EVP Capital Management AG |
Germany |
Xue, James (Canbridge Life Sciences 201507 CEO) |
Chief Executive Officer (CEO) |
Canbridge Life Sciences Ltd. (CN) |
|
Xu, Yao-Chang (Abbisko Therapeutics 2023 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Abbisko Therapeutics Co. Ltd. |
China |
Xu, Caroline Man (ViGeneron 201911 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
ViGeneron GmbH |
Germany |
Xinguang, Zhu (Chinese Academy of Sciences 201706 Prof at SIPPE) |
Professor |
China (govt) |
China |
Xia, Xiaokai (Sinopharm 202208 Managing Director of Shanghai GeneoDx) |
Managing Director |
Sinopharm (China National Pharmaceutical) (Group) |
China |
Xi, Zhang (Superlab Suisse 2019– CEO + Founder) |
Chief Executive Officer (CEO) |
Superlab Suisse (Group) |
Switzerland |
Xi, Hualin (Simon) (Rgenta Therapeutics 202004 CEO + CO-Founder) |
Chief Executive Officer (CEO) |
Rgenta Therapeutics Inc. |
United States (USA) |
Wölfl, Stefan |
n. a. |
University of Heidelberg (Ruperto Carola) |
Germany |
Wüstenberg, Arne (Celldeg GmbH 201609– Managing Director) |
Managing Director |
Celldeg GmbH |
Germany |